Voyager Therapeutics Appoints Toby Ferguson As Chief Medical Officer
(RTTNews) - Biotechnology company Voyager Therapeutics, Inc. (VYGR) announced the appointment of Toby Ferguson as Chief Medical Officer (CMO), effective March 25, 2024. Ferguson most recently served as Vice President, Head of Neuromuscular Development Unit at Biogen, Inc.
Joining Biogen in 2013, Ferguson held positions of increasing responsibility, including as Medical Director, Senior Medical Director, Executive Medical Director, and culminating his time at Biogen as Vice President, Head of Neuromuscular Development Unit.
During his tenure, Ferguson built and developed teams focused on neuromuscular and movement disorders, overseeing strategy for these areas across Biogen R&D.
Prior to joining Biogen, Ferguson was Assistant Professor of Neurology, Shriners Pediatric Research Center and Temple University School of Medicine.
Sensex, Nifty End Choppy Session Little Changed
European Shares Inch Higher In Cautious Trade
Asian Shares Modestly Higher Before Pivotal US Jobs Report
European Shares Set For Steady Open Before US Jobs Report
Sensex, Nifty Open Higher On Fed Rate Cut Hopes
Australian Market Trims Early Gains In Mid-market
Asian Markets Track Wall Street Higher
